Trial intelligence / Profile preview

Fluorescence-Guided Surgery and Intraoperative PDT in Colorectal Cancer

NCT06307548Phase 2Recruiting

Sponsor
Roswell Park Comprehensive Cancer Center
Start
Jul 2024
Primary completion
Jun 2029
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 5-aminolevulinic acid in colorectal cancer (CRC), sponsored by Roswell Park Comprehensive Cancer Center. Started Jul 2024; status: recruiting.

02

Drugs

5-aminolevulinic acid
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT06307548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06307548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call